Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 107971
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.107971
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.107971
Figure 1 SAC3 domain containing 1 is upregulated in liver hepatocellular carcinoma and is associated with tumor grade and disease prognosis.
aP < 0.05, bP < 0.01, cP < 0.001. A: Analysis of SAC3 domain containing 1 (SAC3D1) expression across different cancers using UALCAN database; B: Analysis of SAC3D1 expression in liver hepatocellular carcinoma and adjacent tissues using gene expression profiling interactive analysis; C: Correlation between high and low SAC3D1 expression and overall survival and progression-free survival in liver hepatocellular carcinoma patients, as analyzed by gene expression profiling interactive analysis; D: Correlation between SAC3D1 transcription levels and tumor stages; E: Correlation between SAC3D1 transcription levels and tumor grades; F: Correlation between SAC3D1 transcription levels and lymph node metastasis; G: Correlation between SAC3D1 transcription levels and gender; H: Correlation between SAC3D1 transcription levels and age. SAC3D1: SAC3 domain containing 1; LIHC: Liver hepatocellular carcinoma; TCGA: The Cancer Genome Atlas; NS: No significance.
- Citation: Lin XJ, Tang EJ, Sun B, Wang AL, Chen Y, Chen L, Xue YY, Li AJ, Liu CY. SAC3 domain containing 1 intervention in energy metabolism reprogramming assists in the progression of hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(7): 107971
- URL: https://www.wjgnet.com/1948-5204/full/v17/i7/107971.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i7.107971